Antheia Stock

antheia.bioHealthcareFounded: 2013Funding to Date: $136.64MM

Antheia is the developer of a novel whole-cell engineering approach to reconstruct complex molecules in yeast and a platform designed to enables the discovery and manufacturing of plant-inspired drugs of unprecedented complexity and diversity.

Register for Details

For more details on financing and valuation for Antheia, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Antheia.

Register Today

Other companies like Antheia in the Healthcare sector

Sector
Last Round Est. Valuation
$2.15B
Sector
Last Round Est. Valuation
$3.67B
Sector
Last Round Est. Valuation
$303.94MM
Sector
Last Round Est. Valuation
$298.33MM
Sector
Last Round Est. Valuation
$1.08B
Sector
 
 
Sector
Last Round Est. Valuation
$334.19MM
Sector
Last Round Est. Valuation
$4.26B